Published November 1, 2024
Many suspect that remnants consisting of SARS-CoV-2 protein may be causing Long COVID symptoms in some individuals. A new study supported by RECOVER, found that people with Long COVID were 2X as likely to have viral remnants in their blood as people with no lingering symptoms. 21% of study participants had detectable levels of a SARS-CoV-2 protein in their blood between 4 and 7 months after infection. More research is needed for treatments of Long COVID and RECOVER is currently looking at whether the antiviral drug Paxlovid could also be used to improve Long COVID symptoms.
When: Tuesday, December 10, 2024, at 12:00 PM EST
Who: The Foundation for the National Institutes of Health
What: Persistent SARS-CoV-2 antigens and correlation with Long COVID symptoms: Findings from a multi-cohort study.
Where: Zoom
COVID-19 infections are proposed to be able to take advantage of less-than-perfect health to cause persistent symptoms like influenza. The long-lasting and poorly understood symptoms of Long COVID merit particular attention and healthcare providers must listen to the experiences of patients who are suffering with this novel illness. Yale Medicine understands that, therefore, they interview an individual who has Long COVID and a preexisting condition (encephalomyelitis/chronic fatigue syndrome (ME/CFS) and his experience with both.
It has been determined that Long COVID can cause billions lost in the economy; Long COVID symptoms have been known to significantly diminish quality of life, increase disability, and result in economic loss in workdays lost to illness. A study conducted in the United Kingdom concluded that 36% of participants were unable to work at all and 72% participants who reported loss of working days when they first started the study continued reporting working days lost 6 months later. In addition, women are more likely to report Long COVID than men; one hypothesis is that COVID triggers overactive gene expression in women that leads to persistent symptoms. Research is being conducted to look at cell to cell communication between men and women that report Long COVID symptoms; women in the study showed an expression of several genes that encode proteins involved in inflammation and one of those genes is linked to autoimmunity conditions. Finding from these studies could guide future research.
Follow us to stay in the loop about the latest long COVID news and for long COVID updates in Western New York.
Find us on:
If you had COVID-19 and would like to participate, begin filling out the questionnaire.
If you have already participated in the Long COVID Connection, feel free to share with others who may be interested.
Contact us: (716) 382 - 1808 / ubcov@buffalo.edu